# Tirzepatide SURMOUNT-MAINTAIN: keeping weight off | PepVault

Source: https://pepvault.app/research/tirzepatide-surmount-maintain-2026

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Research](https://pepvault.app/research) [Tirzepatide](https://pepvault.app/research#tirzepatide)

Randomized trial · people

# Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks

Checked against the paper November 2026 Randomized trial [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The takeaway

Keeping tirzepatide at the full tolerated dose held weight off best over a further year, a lower 5 mg dose kept much of the loss, and switching to placebo led to regain in many people.

- **Kind:** Randomized trial
- **Studied in:** People
- **Number studied:** 378
- **Published:** 2026
- **Journal:** Lancet

## What they tested

After weight loss on tirzepatide, does staying on the top tolerated dose or dropping to 5 mg keep the weight off better than switching to placebo?

## How the study was done

A phase 3b, double-blind, randomized, placebo-controlled trial at 20 US sites in adults with obesity, or overweight plus a weight-related health problem. Everyone first took weekly tirzepatide injections at their maximum tolerated dose (MTD, 10 mg or 15 mg) for 60 weeks, then 378 people were split to stay on the MTD (140), drop to 5 mg (144) or switch to placebo, a dummy shot (94), for 52 more weeks.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking tirzepatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What they found

From the start of the trial to week 112, body weight changed by -21.9% in the MTD arm, -16.6% in the 5 mg arm and -9.9% in the placebo arm, and both tirzepatide arms beat placebo (p<0.0001). Rescue tirzepatide, offered from week 84 to people who regained more than 50% of the weight they had lost, went to 11 of 138 (8%) in the MTD arm, 35 of 142 (25%) in the 5 mg arm and 60 of 90 (67%) in the placebo arm. The most common side effects with tirzepatide were stomach and gut problems, mostly mild to moderate and mostly during dose increases.

## What it doesn’t show

Only people who finished the 60-week weight-loss phase on tirzepatide were randomized, and the placebo arm could get rescue tirzepatide, so this is not a test of stopping with no further treatment. The trial ran only in the USA, most participants were White and female, and it was funded by Eli Lilly.

## The paper

Horn et al. Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2026.

- [PubMed (PMID 42119587)](https://pubmed.ncbi.nlm.nih.gov/42119587/)
- [The paper (DOI 10.1016/S0140-6736(26)00656-2)](https://doi.org/10.1016/S0140-6736%2826%2900656-2)
- [ClinicalTrials.gov (NCT06047548)](https://clinicaltrials.gov/study/NCT06047548)

## The compound

- [Tirzepatide: how it works, half-life, studied range and evidence](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

## With this study

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Mazdutide vs Tirzepatide](https://pepvault.app/peptides/compare/mazdutide-vs-tirzepatide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)
- [Tirzepatide vs Dulaglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-dulaglutide)
- [Orforglipron vs Tirzepatide](https://pepvault.app/peptides/compare/orforglipron-vs-tirzepatide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)

## More studies on Tirzepatide

- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026) Randomized trial · people · 2026
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025) Randomized trial · people · 2025
- [Tirzepatide: up to 19.7% weight loss at 176 weeks in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2025-39536238) Randomized trial · people · 2025
- [Tirzepatide: about 75% of weight lost was fat in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-2025-39996356) Randomized trial · people · 2025
- [Tirzepatide: most reached a weight plateau by week 72 in SURMOUNT-1](https://pepvault.app/research/tirzepatide-surmount-1-and-surmount-4-2025) Randomized trial · people · 2025
- [Tirzepatide: 20.2% weight loss vs 13.7% on semaglutide at 72 weeks](https://pepvault.app/research/tirzepatide-surmount-5-2025) Randomized trial · people · 2025
- [Every study on Tirzepatide](https://pepvault.app/research#tirzepatide)

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed November 2026. Spot an error? [feedback@pepvault.app](mailto:feedback@pepvault.app). [How we research](https://pepvault.app/guides/how-we-research). This page reports one study; it is not medical advice.

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking tirzepatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking tirzepatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this study

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Retatrutide vs Tirzepatide](https://pepvault.app/peptides/compare/retatrutide-vs-tirzepatide)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Mazdutide vs Tirzepatide](https://pepvault.app/peptides/compare/mazdutide-vs-tirzepatide)
- [Tirzepatide vs Liraglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-liraglutide)
- [Tirzepatide vs Dulaglutide](https://pepvault.app/peptides/compare/tirzepatide-vs-dulaglutide)
- [Orforglipron vs Tirzepatide](https://pepvault.app/peptides/compare/orforglipron-vs-tirzepatide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Terms on this page

- [Placebo](https://pepvault.app/glossary/placebo)
- [Double-blind](https://pepvault.app/glossary/double-blind)

<!--promo-->

PepVault for iPhone

## Taking tirzepatide? Keep your own record

Log each dose, your weight and how you feel, in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=study-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## Research

- [All studies](https://pepvault.app/research)
- [Every study on Tirzepatide](https://pepvault.app/research#tirzepatide)

## The library

- [Tirzepatide](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)
- [The peptide reference library](https://pepvault.app/peptides)

## How we work

- [How we research](https://pepvault.app/guides/how-we-research)
- [How we check the library](https://pepvault.app/about#library)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, Victoza and Trulicity are trademarks of their respective owners; PepVault is independent and not affiliated with or endorsed by any manufacturer.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
